These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30943160)

  • 1. [Anticipating changes and risks in adults - From label to delivery of an innovative treatment: what a journey! (2)].
    Antoine JC
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():35-36. PubMed ID: 30943160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Following together the road to accessing innovative therapies: a few landmarks].
    Cottet C
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():57-59. PubMed ID: 30943167
    [No Abstract]   [Full Text] [Related]  

  • 3. [An institutional point of view - From label to delivery of an innovative treatment: what a journey! (4)].
    Belcastro J
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():39-41. PubMed ID: 30943162
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences and reflections in the paediatric context - From label to delivery of an innovative treatment: what a journey! (1)].
    Cancès C
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():32-34. PubMed ID: 30943159
    [No Abstract]   [Full Text] [Related]  

  • 5. [The organization of pharmacovigilance in France, in Europe and worldwide - From label to delivery of an innovative treatment: what a journey! (3)].
    Lebrun-Vignes B
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():37-39. PubMed ID: 30943161
    [No Abstract]   [Full Text] [Related]  

  • 6. [Accompanying patients in the arrival of new treatments. The AFM-Téléthon regional services experience - Clinical use of innovative, repurposed or off-label therapies: a real life experience (3)].
    Merret G
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():26-27. PubMed ID: 30943157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Late-onset Pompe disease: the lessons drawn from the use of Myosime
    Laforêt P
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():18-21. PubMed ID: 30943155
    [No Abstract]   [Full Text] [Related]  

  • 8. [Innovative therapies and organization of care facilities].
    Desguerre I; Perreau-Saussine M; Annane D; Solé G
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():51-53. PubMed ID: 30943165
    [No Abstract]   [Full Text] [Related]  

  • 9. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving service delivery for neuromuscular diseases: a survey of consumers at a tertiary Australian hospital.
    Anderson J; Tay G; Denby G; Robinson J; Douglas J; Robinson P; Curtin D
    Intern Med J; 2018 Dec; 48(12):1520-1524. PubMed ID: 30517984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bill to protect doctors who try experimental treatments starts journey through UK parliament.
    Dyer C
    BMJ; 2014 Jun; 348():g3696. PubMed ID: 24895250
    [No Abstract]   [Full Text] [Related]  

  • 12. [Towards a better organisation of care for rare diseases in France: a health professional perspective].
    Jondeau G
    Med Sci (Paris); 2018 May; 34 Hors série n°1():11-13. PubMed ID: 29911545
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethics codes and use of new and innovative drugs.
    Borysowski J; Ehni HJ; Górski A
    Br J Clin Pharmacol; 2019 Mar; 85(3):501-507. PubMed ID: 30536603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 15. New investigational therapies for gastroesophageal reflux disease.
    Richter JE
    Thorac Surg Clin; 2005 Aug; 15(3):377-84. PubMed ID: 16104128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Which follow-up for innovative treatments?].
    Campana-Salort E; Espil-Taris C; Prigent H; de Antonio M; Lebrun-Vignes B; Tiffreau V; Honnet G
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():54-56. PubMed ID: 30943166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Innovative drugs for the good of the patients].
    Dietrich W
    Krankenpfl J; 2005; 43(4-6):136. PubMed ID: 16171078
    [No Abstract]   [Full Text] [Related]  

  • 18. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical error management.
    Stiegler MP; Chidester T; Ruskin KJ
    Int Anesthesiol Clin; 2013; 51(4):22-36. PubMed ID: 24088886
    [No Abstract]   [Full Text] [Related]  

  • 20. Transforming care delivery. Doctors, patients, families acting as a team can lead to improved healthcare.
    Chu B
    Mod Healthc; 2013 May; 43(21):26. PubMed ID: 23947102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.